ASSESMENT OF PLASMA RANDOM BLOOD GLUCOSE AND GLYCATED HAEMOGLOBIN LEVELS IN HYPERTENSIVE SUBJECTS IN SOME HOSPITALS IN ANAMBRA STATE, NIGERIA.
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2018, Vol 7, Issue 7
Abstract
Hypertension is an important and major global public health problem.This study is designed to assess plasma random blood glucose and glycated hemoglobin levels in hypertensive (non-diabetic) subjects in some hospitals in Anambra state, Nigeria. A total of 80 subjects were recruited (40 non-diabetic hypertensive and 40 normotensive non-diabetic who served as the control group). Blood samples were collected from the non-diabetic hypertensive subjects as well as the control group. Plasma random blood glucose levels were estimated by the Glucose Oxidase Method while glycated hemoglobin levels were determined using spectrophotometric method. The mean glycated haemoglobin (Hb/Ac) and plasma random blood glucose (RBG) levels in non-diabetic hypertensive subjects were significantly higher when compared to control group (p=0.000). The correlation of plasma RBG levels and Hb1Ac to diastolic blood pressure (DBP) in non-diabetic hypertensive subjects were not significantly different when observed among the group (p>0.05). However, a positive weak correlation was observed in the mean Hb1Ac (r=0.045) of the non –diabetic hypertensive. In contrast, no significant difference was observed in the correlation of plasma RBG levels and Hb1Ac to systolic blood pressure (SBP) in non-diabetic hypertensive subjects (p>0.05). Interestingly, the mean plasma RBG and Hb1Ac levels did not differ significantly when compared among different age groups in non-diabetic hypertensive subjects (p>0.05). Moreover, the mean plasma RBG levels and Hb1Ac in non-diabetic hypertensive subjects taking antihypertensive medication and those not taking medication were not significantly (p>0.05) different when compared among the groups (p>0.05). Therefore, it was observed that non-diabetic hypertensive subjects are at risk of developing diabetes as their diastolic blood pressure increases in the near future.
Authors and Affiliations
Ogbodo E. C.
Keywords
Related Articles
- EP ID EP627424
- DOI -
- Views 138
- Downloads 0
ANALYSIS OF THE EFFECT OF LEVODOPA ON NEUROTRANSMITTERS USING QUANTITY METHOD
The Benefit of the Levodopa or L-Dopa (LEV) to reduce the symptoms of Parkinson’s disease and have been studied and presented a concern for promoting the acceleration of neurodegeneration. The objective of the study is t...
ACUTE AND SUB-CHRONIC NEPHROTOXICITY STUDY ON ORALLY ADMINISTERED LEAF EXTRACT OF SPONDIAS MOMBIN IN MALE WISTAR ALBINO RAT
Introduction: Spondias mombin has been reported to possess medicinal properties. Method: The preliminary phytochemical analysis was determined by the method described by Harbone 1973 and sofowora, 1982 and the Lethal dos...
CHEMICAL-QUANTUM ANALYSIS OF THE AGGRESSIVENESS OF GLUCOSE AND ITS APPEASEMENT WITH ATP INSIDE THE CELL, AND WATER AS AN EXCELLENT ANTIOXIDANT
Glucose (GLU) is the molecule that provides energy for all our biological functions. Insulin controls the GLU in the bloodstream until it is introduced into the cell. The objective of this work was to investigate which b...
SIRT-1 ACTIVATORS –IN DIABETIC NEPHROPATHY
Sirtuin plays important role in renoprotection, SIRT-1 is key when activated by drugs like Resveratrol, Roflumilast, Grape seed, Panax ginseng, Glycyrrhizic acid provided renal protection in diabetic model. SIRT-1 activa...
IN VITRO REGULATION OF ADIPOGENIC DIFFERENTIATION OF ADIPOSE-DERIVED MESENCHYMAL STEM CELLS
Human adipose tissue acts as a practical supply of mesenchymal stem cells (hAMSCs) compared to other donor sites. So our attention was directed to study the adipogenic differentiation capacity of mesenchymal stem cells d...